Fernando Gonzalez-Ortiz

Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease

K. Blennow, E. Vanmechelen, H. Zetterberg, 2022, Alzheimer's research & therapy.

Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications

K. Blennow, H. Zetterberg, T. Karikari, 2023, Molecular Neurodegeneration.

Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring

Sterling C. Johnson, Alexa Pichet Binette, K. Blennow, 2022, Nature Medicine.

A novel ultrasensitive assay for plasma p‐tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease

K. Blennow, V. Villemagne, M. Suárez-Calvet, 2023, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays

K. Blennow, E. Vanmechelen, H. Zetterberg, 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology

K. Blennow, M. Thambisetty, T. Karikari, 2023, medRxiv.